Aurora Cannabis (ACB) Accounts Payables (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Accounts Payables data on file, last reported at $48.8 million in Q4 2025.

• Accounts Payables for Q4 2025 came in at $48.8 million, down 2.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $48.8 million (down 2.59% YoY), and the FY2025 annual result was $51.3 million, up 18.03% from the prior year.
• Accounts Payables improved to $48.8 million in Q4 2025 per ACB's latest filing, from $35.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $74.1 million in Q3 2022 and troughed at $28.6 million in Q3 2024.
• A 5-year average of $46.9 million and a median of $46.1 million in 2023 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2021 and 2022: Accounts Payables slumped 57.26% in 2021, then jumped 71.03% in 2022.
• A 5-year view of Accounts Payables shows it stood at $41.9 million in 2021, then jumped by 34.08% to $56.2 million in 2022, then dropped by 18.49% to $45.8 million in 2023, then advanced by 9.39% to $50.1 million in 2024, then retreated by 2.59% to $48.8 million in 2025.
• Business Quant data shows ACB's Accounts Payables at $48.8 million in Q4 2025, $35.9 million in Q3 2025, and $58.7 million in Q2 2025.